What are the pathogenic mechanisms by which airway epithelial injury leads to subglottic stenosis and what is the recommended diagnostic and therapeutic approach?

Airway Epithelium and Subglottic Stenosis: Pathogenesis and Management

Pathogenic Mechanisms of Epithelial Injury Leading to Subglottic Stenosis

Endotracheal intubation causes direct mechanical trauma to the airway epithelium, initiating a cascade of mucosal inflammation, local hypoxia, and biomechanical stress that triggers dysregulated tissue repair and pathological fibrosis. 1

Acute Epithelial Injury Spectrum

• Epithelial damage after endotracheal intubation is nearly universal, ranging from focal epithelial necrosis over the arytenoid or cricoid cartilages to extensive mucosal necrosis of the trachea. 2
• The initial injury creates a local micro-environment characterized by mucosal inflammation, tissue hypoxia, and ongoing mechanical stress from the endotracheal tube. 1
• Superficial lesions seen immediately after extubation frequently resolve without sequelae, making the relationship between acute damage and chronic stenosis unpredictable. 2

Progression to Fibrotic Stenosis

• The abnormal healing process involves excess tissue deposition driven by the altered local environment created by intubation. 1
• This pathological repair results in circumferential fibrotic scar tissue that progressively narrows the subglottic airway. 3

Risk Factors for Acquired Subglottic Stenosis

Critical Intubation Parameters

• Intubation duration ≥7 days or ≥3 separate intubations are the primary risk factors for both laryngeal injury and acquired subglottic stenosis. 2, 4
• Inappropriately large endotracheal tubes (tube size-to-gestational age ratio >0.1) significantly increase stenosis risk. 2
• When appropriate tube sizing is used, gestational age and birth weight alone do not predict stenosis development. 2

Incidence Data

• Retrospective studies report acquired subglottic stenosis in 1.7-8% of previously intubated neonates. 2
• Prospective studies demonstrate higher rates of 9.8-12.8%, likely reflecting more systematic surveillance. 2, 4

Common Pitfall

Early endoscopy after extubation overestimates long-term damage risk—do not make definitive surgical decisions based solely on immediate post-extubation findings. 2

Diagnostic Approach

Clinical Presentation

• Postextubation stridor is the most significant clinical marker for moderate to severe subglottic stenosis. 2, 4
• Fixed glottic or subglottic lesions produce biphasic stridor, whereas dynamic lesions cause only inspiratory stridor. 2, 4
• In preterm infants, apnea and bradycardia may replace stridor due to easy fatigability and paradoxical hypoxemic response. 2, 4
• Additional manifestations include hoarseness, failure to tolerate extubation, and cyanosis or pallor. 2

Differential Diagnosis

Rule out vocal cord injuries, glottic or subglottic webs or cysts, laryngomalacia, and extrathoracic tracheomalacia, which produce similar presentations. 2

Diagnostic Evaluation

• Direct visualization via fiberoptic bronchoscopy (standard pediatric 3.6-mm scope) is mandatory to confirm diagnosis and assess stenosis severity. 2, 5
• Management should involve an otolaryngologist or pulmonologist with specific expertise in airway lesions. 5, 6

Therapeutic Approach

Prevention Strategies

• Use nasal CPAP instead of endotracheal intubation whenever possible—in one series of 201 premature infants managed with nasal CPAP, zero cases of subglottic stenosis occurred. 2
• Minimize intubation duration and number of reintubations. 2
• Select appropriate endotracheal tube size (tube size-to-gestational age ratio <0.1) to prevent acquired stenosis. 5, 6
• Prophylactic antibiotics are NOT recommended—no data support their use in preventing subglottic stenosis. 5

Treatment Algorithm for Idiopathic/Post-Intubation Stenosis

First-Line: Serial Endoscopic Dilation

• Serial endoscopic dilations combined with intralesional corticosteroid injections are the standard initial approach for idiopathic or non-inflammatory subglottic stenosis. 6
• Balloon dilation under direct visualization or fluoroscopic guidance effectively treats distal tracheal and bronchial stenoses. 5

Second-Line: Surgical Intervention

• If endoscopic management fails, anterior cricoid split is the preferred initial surgical technique, allowing subglottic space widening and healing without tracheostomy. 5, 6
• If anterior cricoid split fails or criteria are not met, tracheostomy is mandatory to bypass obstruction, though this delays speech development and increases care complexity. 5
• Laryngotracheal reconstruction can be performed gradually after tracheostomy placement. 5
• Cricotracheal resection for refractory cases shows a 13% long-term recurrence rate with mean time to recurrence of 12.5 years. 7

Treatment of Inflammatory/Vasculitic Stenosis (GPA)

Medical Management

• For actively inflamed subglottic stenosis in granulomatosis with polyangiitis (GPA), first-line treatment is systemic glucocorticoids combined with rituximab or cyclophosphamide. 5, 6, 3
• Treatment intensity should be calibrated to the severity of extra-airway organ involvement. 5, 6
• Mandatory Pneumocystis jirovecii prophylaxis is required for patients receiving rituximab (≥6 months after last dose) or cyclophosphamide. 5, 6

Surgical Timing in GPA

• Surgical dilation with intralesional glucocorticoid injection should be reserved for longstanding, fibrotic stenoses unresponsive to immunosuppression. 5, 6
• Concurrent surgical dilation may be considered alongside medical treatment only when immediate intervention is required for critical airway narrowing. 5
• Do not perform surgical dilation alone for actively inflamed GPA-related stenosis—immunosuppression must be the primary treatment. 5

Acute Exacerbation Management

• Racemic epinephrine provides temporary relief for mild to moderate stenosis during upper respiratory infections by reducing superimposed edema. 5
• Systemic corticosteroids have been used early in the stenosis course, though formal efficacy data are lacking. 5

Key Clinical Distinction

GPA-related stenoses are typically circumferential and subglottic (85% of cases), whereas relapsing polychondritis stenoses are anterior, tracheal, calcified, and extend to bronchi (86%). 3 This distinction guides both diagnostic workup and treatment planning.